Heidi, the fast-growing healthcare AI company, today announced the launch of its regional hub in Singapore, following its recent US$65 million Series B funding round led by Point72 Private Investments.
The Singapore office will serve as Heidi’s regional headquarters in Southeast Asia, underscoring the company’s long-term commitment to the market. Heidi plans to invest up to US$8 million over the next two to three years, focused on building local teams across sales, implementation, and clinical partnerships, with an estimated hiring target of 10–12 roles during this period. The company expects to expand the team further as the business grows, supporting customer success, research collaborations, and partnerships with leading healthcare institutions.
Heidi’s entry comes as Singapore faces pressure on its healthcare system, driven by an ageing population and a shortage of clinicians. By 2030, one in four Singaporeans will be aged 65 or older, with one doctor per 343 residents, a challenge that will only intensify as the population ages.
